OncoTherapy Science Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.8%.

Top 18 shareholders own 14.89% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.61%	Yusuke Nakamura	12,511,000	€2.5m	0%	no data
2.15%	Shuichi Nakatsuru	5,850,000	€1.2m	0%	no data
1.45%	Yoichi Furukawa	3,943,000	€786.8k	0%	no data
1.14%	Central Tanshi Co., Ltd., Asset Management Arm	3,099,600	€618.5k	0%	0.29%
0.92%	Hirofumi Arakawa	2,487,400	€496.4k	0%	no data
0.82%	Japan Securities Finance Co. Ltd., Asset Management Arm	2,225,100	€444.0k	0%	0.01%
0.74%	Long Corridor Asset Management Limited	2,000,000	€399.1k	-75.6%	0.44%
0.58%	Matsui Securities Co. Ltd., Asset Management Arm	1,570,300	€313.3k	0%	0.21%
0.42%	Simplex Asset Management Co., Ltd.	1,136,100	€226.7k	0%	0.02%
0.41%	SBI Holdings Inc., Asset Management Arm	1,114,211	€222.3k	0%	0.01%
0.37%	Katsumi Suzuki	1,000,000	€199.5k	0%	no data
0.36%	Kazuko Kitamura	978,000	€195.2k	0%	no data
0.31%	Hiroshi Takeuchi	850,000	€169.6k	0%	no data
0.3%	Takashi Maruta	828,000	€165.2k	0%	no data
0.29%	Koji Toyooka	783,900	€156.4k	0%	no data
0.018%	Yuka Yamane	50,000	€10.0k	0%	no data
0.011%	Miyako Takagi	31,000	€6.2k	0%	no data
0.00029%	Daiwa Asset Management Co., Ltd.	800	€157.2	0%	no data